Editorial Board

Editors-in-Chief

Primo Nery Lara

Primo N. Lara, Jr., MD
University of California Davis
Comprehensive Cancer Center

Sacramento, CA, USA
Email: kca@iospress.com
(Epidemiology, Pathogenesis, Pharmacology, Diagnosis, Treatment, Survivorship)

 

Peter Mulder

Peter Mulders, MD, PhD
Radboud UMC
Nijmegen, The Netherlands
Email: kca@iospress.com
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment, Survivorship)

Associate Editors

Neeraj Agarwal, MD
Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
(Diagnosis, Treatment, Survivorship)

Laurence Albiges, MD, PhD
Gustave Roussy, Université Paris Saclay, Villejuif, France
(Epidemiology, Pharmacology, Diagnosis, Treatment, Survivorship)

Axel Bex, MD, PhD
Netherlands Cancer Institute, Amsterdam, The Netherlands
(Epidemiology, Diagnosis, Treatment)

Toni K. Choueiri, MD
Dana-Farber Cancer Institute, Boston, MA, USA
(Molecular Genetics, Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment, Survivorship)

Enrique Grande, MD
MD Anderson Cancer Center Madrid, Madrid, Spain
(Epidemiology, Diagnosis, Treatment, Survivorship)

Viktor Grünwald, MD
University Hospital Essen, Essen, Germany
(Etiology, Diagnosis, Treatment)

Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
(Etiology, Molecular Genetics, Pharmacology, Diagnosis, Treatment, Survivorship)

Bradley C. Leibovich, MD
Mayo Clinic, Rochester, MN, USA
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Diagnosis, Treatment)

Egbert Oosterwijk, PhD
Radboud UMC, Nijmegen, The Netherlands
(Diagnosis, Treatment, Survivorship)

Javier Puente, MD, PhD
Hospital Clinico Universitario San Carlos, Madrid, Spain
(Diagnosis, Treatment, Survivorship)

Sandy Srinivas, MD
Stanford University, Stanford, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Hirotsugu Uemura, MD, PhD
Kindai University Faculty of Medicine, Osaka, Japan
(Diagnosis, Treatment)

Social Media Editor

Neeraj Agarwal, MD
Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
(Diagnosis, Treatment, Survivorship)

Associate Editor for Reviews 

Enrique Grande, MD
MD Anderson Cancer Center Madrid, Madrid, Spain
(Epidemiology, Diagnosis, Treatment, Survivorship)

Sumanta Pal, MD
City of Hope, Duarte, CA, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Editor of Clinical Trials Corner 

Mamta Parikh, MD
UC Davis Comprehensive Cancer Center, Sacramento, CA, USA
(Diagnosis, Treatment, Survivorship)

 

Editorial Board 

Hideyuki Akaza, MD
University of Tokyo, Tokyo, Japan
(Pathogenesis, Diagnosis, Treatment)

Georg A. Bjarnason, MD, FRCP(C)
Sunnybrook Odette Cancer Center, Toronto, ON, Canada
(Molecular Genetics, Pharmacology, Diagnosis, Treatment, Survivorship)

James Brugarolas, MD, PhD
University of Texas Southwestern Medical Center, Dallas, TX, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Diagnosis, Treatment)

Ronald M. Bukowski, MD
Cleveland Clinic Foundation, Cleveland, USA
(Diagnosis, Treatment, Survivorship)

Steven C. Campbell, MD, PhD
Cleveland Clinic, Cleveland, OH, USA
(Epidemiology, Diagnosis, Treatment, Survivorship)

Marc Dall’era, MD
UC Davis Comprehensive Cancer Center, Sacramento, CA, USA
(Epidemiology, Diagnosis, Treatment)

Tanya B. Dorff, MD 
City of Hope, Duarte, CA, USA
(Diagnosis, Treatment)

Janice P. Dutcher, MD
Cancer Research Foundation, Chappaqua, NY, USA
(Epidemiology, Diagnosis, Treatment, Survivorship)

Tim Eisen, PhD, FRCP
University of Cambridge and Roche (VP and Global Head of GU Oncology Product Development), Cambridge, United Kingdom
(Pathobiology, Pharmacology, Diagnosis, Treatment)

Bernard Escudier, MD
Institut Gustave Roussy, Villejuif, France
(Etiology, Pathobiology, Pharmacology, Diagnosis, Treatment)

Robert A. Figlin, MD, FACP
Cedars-Sinai Medical Center, Los Angeles, CA, USA
(Pathobiology, Diagnosis, Treatment, Survivorship)

Thomas (Tom) Flaig, MD
University of Colorado School of Medicine, Aurora, CO, USA
(Diagnosis, Treatment)

Jorge Garcia, MD, FACP
University Hospitals Seidman Cancer Center Case Comprehensive Cancer Center, Cleveland, OH, USA
(Diagnosis, Treatment)

Dan George, MD
Duke University School of Medicine, Durham, NC, USA
(Epidemiology, Pathobiology, Pharmacology, Diagnosis, Treatment)

Ugo De Giorgi, MD
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy
(Diagnosis, Treatment)

Rudolfo De Guzman, MD
National Kidney and Transplant Institute,
Metro Manila, Philippines
(Diagnosis, Treatment)

John Haanen, MD, PhD
Netherlands Cancer Institute, Amsterdam, The Netherlands
(Diagnosis, Treatment)

Naomi Haas, MD
University of Pennsylvania, Philadelphia, PA, USA
(Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment, Survivorship)

Hans Hammers, MD, PhD
University of Texas Southwestern, Dallas, TX, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment)

Michael R. Harrison, MD
Duke Cancer Institute, Durham, NC, USA
(Diagnosis, Treatment)

Daniel Heng, MD, MPH
Tom Baker Cancer Center, Calgary, AB, Canada
(Epidemiology, Diagnosis, Treatment, Survivorship)

Michelle S. Hirsch, MD, PhD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathobiology)

James J. Hsieh, MD, PhD
Washington University School of Medicine, St. Louis, MO, USA
(Molecular Genetics, Pathogenesis, Pathobiology, Diagnosis, Treatment)

Thomas Hutson, DO, PharmD
US Oncology/Baylor, Houston, TX, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Choung Soo Kim, MD, PhD
Asan Medical Center, Seoul, South Korea
(Etiology, Molecular Genetics, Pathobiology, Diagnosis, Treatment)

Christian Kollmannsberger, MD
BC Cancer Agency, Vancouver, BC, Canada
(Diagnosis, Treatment)

James Larkin, MD, PhD
The Institute of Cancer Research, London, United Kingdom
(Diagnosis, Treatment)

Marston Linehan, MD
National Cancer Institute, Bethesda, MD, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Diagnosis, Treatment)

Borje Ljungberg, MD, PhD
Umea University, Umea, Sweden
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment, Survivorship)

Axel S. Merseburger, MD, PhD
University Hospital Schleswig-Holstein, Lübeck, Germany
(Diagnosis, Treatment)

Moshe C. Ornstein, MD
Cleveland Clinic, Cleveland, OH, USA
(Diagnosis, Treatment)

Susanne Osanto, MD, PhD
Leiden University Medical Center, Leiden, The Netherlands
(Diagnosis, Treatment, Survivorship)

Stephane Oudard, MD, PhD
Hôpital Européen Georges Pompidou, Paris, France
(Diagnosis, Treatment)

Allan J. Pantuck, MD
UCLA Institute of Urologic Oncology, Los Angeles, USA
(Molecular Genetics, Pathogenesis, Pharmacology, Diagnosis, Treatment)

Elizabeth Plimack, MD
Fox Chase Cancer Center, Philadelphia, PA, USA
(Diagnosis, Treatment, Survivorship)

Camillo Porta, MD
IRCCS San Matteo University Hospital Foundation, Pavia, Italy
(Diagnosis, Treatment)

Thomas Powles, MD
The Royal Free NHS Trust and Barts Cancer Institute, London, United Kingdom

(Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment)

W. Kimryn Rathmell, MD, PhD
Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment)

Brian Rini, MD
Cleveland Clinic, Cleveland, OH, USA
(Epidemiology, Etiology, Pathogenesis, Pathobiology, Diagnosis, Treatment, Survivorship)

Paul Russo, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
(Diagnosis, Treatment)

Christopher Ryan, MD
Oregon Health Science University, Portland, OR, USA
(Diagnosis, Treatment)

Manuela Schmidinger, MD,
Medical University of Vienna, Vienna, Austria
(Epidemiology, Pharmacology, Diagnosis, Treatment, Survivorship)

Brian Shuch, MD
Yale School of Medicine/Smilow Cancer Center, New Haven, CT, USA
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Diagnosis, Treatment)

Ramaprasad Srinivasan, MD, PhD
National Cancer Institute, Bethesda, MD, USA
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Diagnosis, Treatment)

Walter Stadler, MD
University of Chicago, Chicago, IL, USA
(Epidemiology, Pharmacology, Diagnosis, Treatment)

Mark Stein, MD
Rutgers, The State University of New Jersey, New Brunswick, NJ, USA
(Diagnosis, Treatment)

Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals, Rome, Italy
(Diagnosis, Treatment)

Cezary Szczylik, MD, PhD
Oncology Military Medical Institute, Warsaw, Poland
(Diagnosis, Treatment)

Nizar M. Tannir, MD
MD Anderson Cancer Center, Houston, TX, USA
(Epidemiology, Pharmacology, Diagnosis, Treatment)

Yoshihiko Tomita, MD, PhD
Niigata University, Niigata,
Japan
(Diagnosis, Treatment)

Ilya Tsimafeyeu, MD
Kidney Cancer Research Bureau, Russian Society of Clinical Oncology, Moscow, Russia
(Diagnosis, Treatment)

Robert G. Uzzo, MD
Fox Chase Cancer Center, Philadelphia, PA, USA
(Epidemiology, Etiology, Diagnosis, Treatment)

Ulka Vaishampayan, MD
University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA
(Epidemiology, Pathogenesis, Pharmacology, Diagnosis, Treatment, Survivorship)

Guillermo de Velasco, MD, PhD
Hospital Universitario 12 de Octubre, Madrid, Spain
(Diagnosis, Treatment)

†Nicholas J. Vogelzang, MD
Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, NV, USA
(Diagnosis, Treatment, Survivorship)

Martin H. Voss, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathobiology, Pharmacology, Diagnosis, Treatment)

Stenio Zequi, MD, PhD
AC Camargo Cancer Center, Sao Paulo, Brazil
(Epidemiology, Diagnosis, Treatment)

Patricia Zondervan, MD, PhD
Amsterdam UMC, Amsterdam, the Netherlands
(Etiology, Molecular Genetics, Diagnosis, Treatment)